Tibet Aim Pharm Inc
SZSE:002826

Watchlist Manager
Tibet Aim Pharm Inc Logo
Tibet Aim Pharm Inc
SZSE:002826
Watchlist
Price: 18.74 CNY -1.52%
Market Cap: 3.6B CNY

Wall Street
Price Targets

Price Targets Summary
Tibet Aim Pharm Inc

There are no price targets for Tibet Aim Pharm Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Tibet Aim Pharm Inc Competitors:
Price Targets
NOVN
Novartis AG
6% Upside
SUPN
Supernus Pharmaceuticals Inc
24% Upside
VENUSREM
Venus Remedies Ltd
28% Downside
200670
Humedix Co Ltd
11% Upside
ENZY
Enzymatica AB (publ)
1% Downside
VIRP
Virbac SA
23% Upside
016580
Whanin Pharm Co Ltd
32% Upside
605507
Guobang Pharma Ltd
46% Upside

Revenue
Forecast

Revenue Estimate
Tibet Aim Pharm Inc

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's revenue is 5%. The projected CAGR for the next 8 years is -5%.

5%
Past Growth
-5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Tibet Aim Pharm Inc

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's operating income is 1%. The projected CAGR for the next 8 years is 0%.

1%
Past Growth
0%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Tibet Aim Pharm Inc

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's net income is -2%. The projected CAGR for the next 8 years is 4%.

-2%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tibet Aim Pharm Inc's stock price target?
Not Available

Tibet Aim Pharm Inc doesn't have any price targets made by Wall Street professionals.

What is Tibet Aim Pharm Inc's Revenue forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's revenue is 5%. The projected CAGR for the next 8 years is -5%.

What is Tibet Aim Pharm Inc's Operating Income forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's operating income is 1%. The projected CAGR for the next 8 years is 0%.

What is Tibet Aim Pharm Inc's Net Income forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Tibet Aim Pharm Inc's net income is -2%. The projected CAGR for the next 8 years is 4%.

Back to Top